Imidazoand triazolopyridines as inhibitors of 11-beta hydroxysteroid dehydrogenase type I

Details for Australian Patent Application No. 2006257924 (hide)

Owner Bristol-Myers Squibb Company

Inventors Hamann, Lawrence G.; Robl, Jeffrey A.; Li, James J.; Li, Jun; Cooper, Christopher B.; Ruan, Zheming; Wang, Haixia

Agent A J Park

Pub. Number AU-B-2006257924

PCT Pub. Number WO2006/135795

Priority 60/688,993 09.06.05 US; 11/448,947 07.06.06 US

Filing date 8 June 2006

Wipo publication date 21 December 2006

Acceptance publication date 8 March 2012

International Classifications

C07D 471/04 (2006.01) Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups

A61K 31/435 (2006.01) - having six-membered rings with one nitrogen as the only ring hetero atom

A61P 3/00 (2006.01) Drugs for disorders of the metabolism

Event Publications

6 December 2007 PCT application entered the National Phase

  PCT publication WO2006/135795 Priority application(s): WO2006/135795

8 March 2012 Application Accepted

  Published as AU-B-2006257924

5 July 2012 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006257925-Crystalline forms of a pyrrolotriazine compound

2006257919-Methods of identifying and treating individuals exhibiting mutant kit protein